Plain-English translation of NCT06292494 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called focused ultrasound (FUS) for people with drug-resistant epilepsy — seizures that don't stop even with multiple anti-seizure medications. Focused ultrasound uses highly concentrated sound waves, guided by MRI imaging, to target the brain region where seizures start and reduce abnormal electrical activity. Early research suggests this treatment may significantly decrease seizure frequency and the brain's seizure-related signals.
Many people with epilepsy don't respond to available medications, leaving them with frequent, disabling seizures and limited options. This trial exists to determine whether focused ultrasound is a safe and effective alternative treatment that could help control seizures in patients who have exhausted medication options.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive focused ultrasound treatment during an outpatient procedure at the hospital. You'll be awake during the treatment so you can communicate with the doctor and describe any sensations you feel. The doctor will use real-time MRI imaging to guide the sound waves to the precise area of your brain where seizures start. Your hair at the treatment site will be shaved, and you'll be able to press a stop button at any time if you feel uncomfortable. The research team will monitor your seizures and brain activity before and after treatment to measure whether this approach reduces your seizure frequency.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Taiwan